ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736118 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736118; 2) Community: the network communities that were significantly associated with the response to NSC 736118; 3) Molecule: the relationships between components within communities and NSC 736118; 4) MDR: the compounds that were significantly associated with the NSC 736118.

NSC Compound Enrichment Correlation
NSC 715778 Null 0.0385613993886001 0.12231416
NSC 71669 Null 0.0385613993886001 0.12965427
NSC 716951 Null 0.0385613993886001 0.15756328
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.0385613993886001 0.38633646
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0385613993886001 0.1655925
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0385613993886001 0.067277948
NSC 72961 8-Azadenosine 0.0385613993886001 0.30403923
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0385613993886001 0.31585821
NSC 732178 Null 0.0385613993886001 0.016887083
NSC 740 Methotrexate 0.0385613993886001 0.26630422
Total:146  Current:128    [First] [Prev] [Next] [Last]